インターベンショナル腫瘍焼灼術の世界市場レポート 2025年

インターベンショナル腫瘍焼灼術市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.6％で24億9,000万米ドルに成長します。予測期間中の成長は、軟部組織および転移性腫瘍の発生率の上昇、個別化がん治療戦略への注目の高まり、非外科的腫瘍治療オプションへの需要の高まり、費用対効果の高い腫瘍治療へのシフト、先進的アブレーションデバイスのパイプラインの拡大に起因します。予測期間に予想される主な動向には、併用療法の開発、ハイブリッドアブレーション技術の創出、アブレーションとデータ解析の統合、腫瘍特異的ナノアブレーションの革新、アブレーションシステム技術の進歩などがあります。

がんの有病率の増加は、近い将来、インターベンショナル腫瘍焼灼術市場の成長を大きく押し上げると予想されます。がんは、体内の異常細胞の無秩序な増殖と拡散によって定義される疾患群であり、周囲の組織に浸潤し、血液やリンパ系を介して転移する可能性があります。がん患者の増加は、喫煙、食生活の乱れ、肥満、発がん物質への暴露などの生活習慣や環境要因によるところが大きいです。インターベンショナル腫瘍焼灼術は、低侵襲技術を提供することでがん治療を改善し、患者に手術に代わる方法を提供します。これらの方法は、腫瘍の正確な破壊を可能にすることで治療期間と回復期間を短縮し、患者の転帰と全体的な生活の質を向上させています。例えば、オーストラリア保健福祉研究所の2024年7月の報告書によると、オーストラリアにおけるがんの診断件数は2022年に16万570件に増加し、2021年の15万6,781件から3,789件増加しました。このがん罹患率の増加がインターベンショナル腫瘍焼灼術市場の拡大を牽引しています。

インターベンショナル腫瘍焼灼術市場の主要企業は、BioTraceソフトウェアスイートなどの先進技術ソリューションの開発に注力し、腫瘍切除術の精度と効果を向上させています。BioTraceソフトウェアスイートは、特にヘルスケアや研究環境において、生物学的データを追跡、管理、分析するために設計された統合ツールです。例えば、2024年7月、イスラエルの医療機器会社であるTechsoMed Medical Technologies Ltd.は、画像誘導肝腫瘍焼灼療法の強化を目的としたBioTraceIO VisionおよびBioTraceIO Precisionソフトウェアスイートを発表しました。BioTraceIO Visionは、標準的な医療用画像を使用して、肝腫瘍切除手技の精度と効率を高めるために、パーソナライズされた治療計画と評価のための人工知能（AI）搭載ツールを組み込んでいます。一方、BioTraceIO Precisionは、手技中および手技後のアブレーションゾーンのリアルタイム超音波ベースの可視化と予測マッピングを提供し、臨床医がアブレーション後24時間のCTスキャンと高い相関性を持って組織損傷と治療成果を評価するのを支援します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のインターベンショナル腫瘍焼灼術：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のインターベンショナル腫瘍焼灼術市場：成長率分析
• 世界のインターベンショナル腫瘍焼灼術市場の実績：規模と成長、2019年～2024年
• 世界のインターベンショナル腫瘍焼灼術市場の予測：規模と成長、2024年～2029年、2034年
• 世界のインターベンショナル腫瘍焼灼術：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界のインターベンショナル腫瘍焼灼術市場：処置タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 開腹手術
• 低侵襲手術
• 画像誘導介入
• 世界のインターベンショナル腫瘍焼灼術市場：技術別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 高周波アブレーション（RFA）
• マイクロ波アブレーション（MWA）
• 凍結療法
• レーザーアブレーション
• 高強度焦点式超音波（HIFU）
• 世界のインターベンショナル腫瘍焼灼術市場：デバイスタイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• アブレーションシステム
• 消耗品
• サポートデバイス
• イメージングシステム
• 世界のインターベンショナル腫瘍焼灼術市場：応用分野別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 肝腫瘍
• 腎臓腫瘍
• 肺腫瘍
• 骨腫瘍
• 世界のインターベンショナル腫瘍焼灼術市場：エンドユーザー別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 病院
• 専門がん治療センター
• 外来手術センター
• 研究機関
• 世界のインターベンショナル腫瘍焼灼術市場、開腹手術の種類別のサブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• 腹腔鏡下腫瘍アブレーション
• 開胸腫瘍アブレーション
• 世界のインターベンショナル腫瘍焼灼術市場、低侵襲手術の種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• 経皮的腫瘍アブレーション
• 内視鏡的アブレーション
• 世界のインターベンショナル腫瘍焼灼術市場、画像誘導介入の種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• CTガイド下腫瘍アブレーション
• 磁気共鳴画像誘導腫瘍アブレーション
• 超音波ガイド下腫瘍アブレーション

第7章 地域別・国別分析

• 世界のインターベンショナル腫瘍焼灼術市場：地域別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 世界のインターベンショナル腫瘍焼灼術市場：国別、実績と予測、2019年～2024年、2024年～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• インターベンショナル腫瘍焼灼術市場：競合情勢
• インターベンショナル腫瘍焼灼術市場：企業プロファイル
  • Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis
  • EDAP TMS S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Boston Scientific Corporation
• Olympus Corporation
• Terumo Corporation
• Hologic Inc.
• Elekta
• Conmed Corporation
• Bioventus Inc.
• AtriCure
• AngioDynamics Inc.
• Mermaid Medical Group A/S
• InSightec
• Cascination AG
• H.S. Hospital Service S.p.A
• Theraclion
• IceCure Medical Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• インターベンショナル腫瘍焼灼術市場2029年：新たな機会を提供する国
• インターベンショナル腫瘍焼灼術市場2029年：新たな機会を提供するセグメント
• インターベンショナル腫瘍焼灼術市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Interventional tumor ablation is a minimally invasive procedure that utilizes image-guided techniques to target and destroy cancerous or benign tumors without the need for open surgery. It uses thermal or non-thermal energy to eliminate tumor cells while minimizing damage to surrounding healthy tissue. This procedure is often employed when surgery is not viable or as an alternative to traditional treatments.

The main product types in interventional tumor ablation include open surgery, minimally invasive surgery, and image-guided interventions. Open surgery involves making an incision in the body to access and treat the affected area, typically using scalpels and other instruments. Key technologies in this field include radiofrequency ablation (RFA), microwave ablation (MWA), cryoablation, laser ablation, and high-intensity focused ultrasound (HIFU). Device types used in these procedures include ablation systems, consumables, support devices, and imaging systems. Tumor ablation is frequently applied to liver, kidney, lung, and bone tumors. The end users of these technologies range from hospitals and specialized cancer treatment centers to ambulatory surgical centers and research institutes.

The interventional tumor ablation market research report is one of a series of new reports from The Business Research Company that provides interventional tumor ablation market statistics, including the interventional tumor ablation industry's global market size, regional shares, competitors with the interventional tumor ablation market share, detailed interventional tumor ablation market segments, market trends and opportunities, and any further data you may need to thrive in the interventional tumor ablation market. This interventional tumor ablation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The interventional tumor ablation market size has grown strongly in recent years. It will grow from $1.64 billion in 2024 to $1.79 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth during the historic period can be attributed to the increasing prevalence of liver and kidney cancers, greater awareness of minimally invasive cancer treatments, enhanced availability of diagnostic imaging, a growing geriatric population more susceptible to tumors, and a rising preference for outpatient procedures.

The interventional tumor ablation market size is expected to see strong growth in the next few years. It will grow to $2.49 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth during the forecast period can be attributed to the rising incidence of soft tissue and metastatic tumors, an increasing focus on personalized cancer treatment strategies, growing demand for non-surgical tumor treatment options, a shift toward cost-effective tumor therapies, and an expanding pipeline of advanced ablation devices. Key trends expected in the forecast period include the development of combination therapies, the creation of hybrid ablation techniques, the integration of ablation with data analytics, innovations in tumor-specific nano-ablation, and advancements in ablation system technologies.

The increasing prevalence of cancer is expected to significantly boost the growth of the interventional tumor ablation market in the near future. Cancer, a group of diseases defined by the uncontrolled proliferation and spread of abnormal cells in the body, can invade surrounding tissues and potentially metastasize through the blood and lymphatic systems. The growing number of cancer cases is largely attributed to lifestyle and environmental factors such as smoking, poor diet, obesity, and exposure to carcinogens. Interventional tumor ablation improves cancer treatment by offering minimally invasive techniques, providing patients with an alternative to surgery. These methods shorten treatment time and recovery periods by allowing precise destruction of tumors, which improves patient outcomes and overall quality of life. For example, according to a July 2024 report from the Australian Institute of Health and Welfare, the number of cancer diagnoses in Australia increased to 160,570 in 2022, marking a rise of 3,789 cases from 156,781 in 2021. This growing cancer incidence is driving the expansion of the interventional tumor ablation market.

Leading companies in the interventional tumor ablation market are focusing on developing advanced technological solutions, such as the BioTrace software suite, to improve the precision and effectiveness of tumor ablation procedures. BioTrace software suites are integrated tools designed to track, manage, and analyze biological data, particularly in healthcare and research environments. For example, in July 2024, TechsoMed Medical Technologies Ltd., an Israel-based medical device company, introduced the BioTraceIO Vision and BioTraceIO Precision software suites, aimed at enhancing image-guided liver tumor ablation therapy. BioTraceIO Vision incorporates artificial intelligence (AI)-powered tools for personalized treatment planning and assessment, using standard medical imaging to boost the accuracy and efficiency of liver tumor ablation procedures. BioTraceIO Precision, on the other hand, provides real-time ultrasound-based visualization and predictive mapping of the ablation zone during and after the procedure, helping clinicians evaluate tissue damage and treatment outcomes with high correlation to 24-hour post-ablation CT scans.

In February 2024, Immunophotonics Inc., a US-based biotechnology company, formed a partnership with AngioDynamics Inc. This collaboration aims to combine Immunophotonics' leading immunotherapy asset, IP-001, with AngioDynamics' ablation devices to explore the potential of combining ablation with immunotherapy in treating solid tumor cancers. AngioDynamics Inc., a US-based medical device company, offers microwave and radiofrequency ablation technologies for minimally invasive cancer treatment.

Major players in the interventional tumor ablation market are Johnson And Johnson, EDAP TMS S.A., Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Hologic Inc., Elekta, Conmed Corporation, Bioventus Inc., AtriCure, AngioDynamics Inc., Mermaid Medical Group A/S, InSightec, Cascination AG, H.S. Hospital Service S.p.A, Theraclion, IceCure Medical Ltd.

North America was the largest region in the interventional tumor ablation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in interventional tumor ablation report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the interventional tumor ablation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The interventional tumor ablation market consists of revenues earned by entities by providing services such as electroporation, tumor biopsy services, thermal ablation monitoring, and post-ablation follow-up services. The market value includes the value of related goods sold by the service provider or included within the service offering. The interventional tumor ablation market also includes sales of radiofrequency ablation (RFA) generators, microwave ablation (MWA) systems, cryoablation probes, laser fibers and electrode needles. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Interventional Tumor Ablation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on interventional tumor ablation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for interventional tumor ablation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The interventional tumor ablation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Procedure Type: Open Surgery; Minimally Invasive Surgery; Image-Guided Interventions
• 2) By Technology: Radiofrequency Ablation (RFA); Microwave Ablation (MWA); Cryoablation; Laser Ablation; High-Intensity Focused Ultrasound (HIFU)
• 3) By Device Type: Ablation Systems; Consumables; Support Devices; Imaging Systems
• 4) By Application Area: Liver Tumors; Kidney Tumors; Lung Tumors; Bone Tumors
• 5) By End User: Hospitals; Specialized Cancer Treatment Centers; Ambulatory Surgical Centers; Research Institutes
• Subsegments:
• 1) By Open Surgery: Laparoscopic Tumor Ablation; Thoracotomy Tumor Ablation
• 2) By Minimally Invasive Surgery: Percutaneous Tumor Ablation; Endoscopic Ablation
• 3) By Image-Guided Interventions: Computed Tomography-Guided Tumor Ablation; Magnetic Resonance Imaging-Guided Tumor Ablation; Ultrasound-Guided Tumor Ablation
• Companies Mentioned: Johnson And Johnson; EDAP TMS S.A.; Medtronic plc; Siemens Healthineers AG; Stryker Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Interventional Tumor Ablation Market Characteristics

3. Interventional Tumor Ablation Market Trends And Strategies

4. Interventional Tumor Ablation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Interventional Tumor Ablation Growth Analysis And Strategic Analysis Framework

• 5.1. Global Interventional Tumor Ablation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Interventional Tumor Ablation Market Growth Rate Analysis
• 5.4. Global Interventional Tumor Ablation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Interventional Tumor Ablation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Interventional Tumor Ablation Total Addressable Market (TAM)

6. Interventional Tumor Ablation Market Segmentation

• 6.1. Global Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Open Surgery
• Minimally Invasive Surgery
• Image-Guided Interventions
• 6.2. Global Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Radiofrequency Ablation (RFA)
• Microwave Ablation (MWA)
• Cryoablation
• Laser Ablation
• High-Intensity Focused Ultrasound (HIFU)
• 6.3. Global Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ablation Systems
• Consumables
• Support Devices
• Imaging Systems
• 6.4. Global Interventional Tumor Ablation Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Liver Tumors
• Kidney Tumors
• Lung Tumors
• Bone Tumors
• 6.5. Global Interventional Tumor Ablation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialized Cancer Treatment Centers
• Ambulatory Surgical Centers
• Research Institutes
• 6.6. Global Interventional Tumor Ablation Market, Sub-Segmentation Of Open Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laparoscopic Tumor Ablation
• Thoracotomy Tumor Ablation
• 6.7. Global Interventional Tumor Ablation Market, Sub-Segmentation Of Minimally Invasive Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Percutaneous Tumor Ablation
• Endoscopic Ablation
• 6.8. Global Interventional Tumor Ablation Market, Sub-Segmentation Of Image-Guided Interventions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Computed Tomography-Guided Tumor Ablation
• Magnetic Resonance Imaging-Guided Tumor Ablation
• Ultrasound-Guided Tumor Ablation

7. Interventional Tumor Ablation Market Regional And Country Analysis

• 7.1. Global Interventional Tumor Ablation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Interventional Tumor Ablation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Interventional Tumor Ablation Market

• 8.1. Asia-Pacific Interventional Tumor Ablation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Interventional Tumor Ablation Market

• 9.1. China Interventional Tumor Ablation Market Overview
• 9.2. China Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Interventional Tumor Ablation Market

• 10.1. India Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Interventional Tumor Ablation Market

• 11.1. Japan Interventional Tumor Ablation Market Overview
• 11.2. Japan Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Interventional Tumor Ablation Market

• 12.1. Australia Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Interventional Tumor Ablation Market

• 13.1. Indonesia Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Interventional Tumor Ablation Market

• 14.1. South Korea Interventional Tumor Ablation Market Overview
• 14.2. South Korea Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Interventional Tumor Ablation Market

• 15.1. Western Europe Interventional Tumor Ablation Market Overview
• 15.2. Western Europe Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Interventional Tumor Ablation Market

• 16.1. UK Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Interventional Tumor Ablation Market

• 17.1. Germany Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Interventional Tumor Ablation Market

• 18.1. France Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Interventional Tumor Ablation Market

• 19.1. Italy Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Interventional Tumor Ablation Market

• 20.1. Spain Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Interventional Tumor Ablation Market

• 21.1. Eastern Europe Interventional Tumor Ablation Market Overview
• 21.2. Eastern Europe Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Interventional Tumor Ablation Market

• 22.1. Russia Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Interventional Tumor Ablation Market

• 23.1. North America Interventional Tumor Ablation Market Overview
• 23.2. North America Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Interventional Tumor Ablation Market

• 24.1. USA Interventional Tumor Ablation Market Overview
• 24.2. USA Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Interventional Tumor Ablation Market

• 25.1. Canada Interventional Tumor Ablation Market Overview
• 25.2. Canada Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Interventional Tumor Ablation Market

• 26.1. South America Interventional Tumor Ablation Market Overview
• 26.2. South America Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Interventional Tumor Ablation Market

• 27.1. Brazil Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Interventional Tumor Ablation Market

• 28.1. Middle East Interventional Tumor Ablation Market Overview
• 28.2. Middle East Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Interventional Tumor Ablation Market

• 29.1. Africa Interventional Tumor Ablation Market Overview
• 29.2. Africa Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Interventional Tumor Ablation Market Competitive Landscape And Company Profiles

• 30.1. Interventional Tumor Ablation Market Competitive Landscape
• 30.2. Interventional Tumor Ablation Market Company Profiles
  • 30.2.1. Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. EDAP TMS S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Interventional Tumor Ablation Market Other Major And Innovative Companies

• 31.1. Boston Scientific Corporation
• 31.2. Olympus Corporation
• 31.3. Terumo Corporation
• 31.4. Hologic Inc.
• 31.5. Elekta
• 31.6. Conmed Corporation
• 31.7. Bioventus Inc.
• 31.8. AtriCure
• 31.9. AngioDynamics Inc.
• 31.10. Mermaid Medical Group A/S
• 31.11. InSightec
• 31.12. Cascination AG
• 31.13. H.S. Hospital Service S.p.A
• 31.14. Theraclion
• 31.15. IceCure Medical Ltd.

32. Global Interventional Tumor Ablation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Interventional Tumor Ablation Market

34. Recent Developments In The Interventional Tumor Ablation Market

35. Interventional Tumor Ablation Market High Potential Countries, Segments and Strategies

• 35.1 Interventional Tumor Ablation Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Interventional Tumor Ablation Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Interventional Tumor Ablation Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer